In contrast, we found that PRPF8 and RAVER1 mRNA levels were significantly upregulated in recurrent ( n = 13) relative to primary ACP ( n = 10) tumours and PRPF40A showed a trend towards increased expression that did not reach statistical significance (Fig. 4 B).
← all excerpts
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.
1
—
—